Equity Overview
Price & Market Data
Price: $0.817
Daily Change: +$0.0218 / 2.67%
Range: $0.80 - $0.85
Market Cap: $63,160,372
Volume: 17,773
Performance Metrics
1 Week: -5.78%
1 Month: -19.26%
3 Months: -12.18%
6 Months: -37.92%
1 Year: -41.88%
YTD: -13.74%
Company Details
Employees: 32
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.